Local recurrence of malignant tumor of urinary bladder (disorder)

RE-ARM Trial

Year Started: 2020

A Randomised phase II trial of Enhancement of efficacy of Atezolizumab by Radiotherapy in Metastatic urothelial carcinoma



Access:
Access restricted at present
Type:
Clinical Trial
Status:
In progress
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Clinical records > 6 months
Followup records > 6 months


Undifferentiated

Adult (> 40 years)

11 - 100 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Macroscopic Assessment % of Sample Set
Whole blood -18°C to -35°C Not applicable 51 - 75%